Literature DB >> 3752939

Reduced cellular uptake of cis-dichlorodiammine-platinum by benzaldehyde.

J M Dornish, J E Melvik, E O Pettersen.   

Abstract

Synchronized human NHIK 3025 cells were treated with cis-dichlorodiammineplatinum (cis-DDP) either alone or in combination with benzaldehyde as a 2 h pulse in G1-phase. After this pulse, the cells entered S-phase and the rate of DNA synthesis was measured by DNA-flow cytometric recordings of serial samples. After treatment with 10 microM cis-DDP alone, the rate of DNA synthesis was 38% of the control rate. If 3.2 mM benzaldehyde was present together with 10 microM cis-DDP, the rate of DNA synthesis was 56% of the control rate, this being similar to the rate measured following treatment of cells with 5 microM cis-DDP alone. Thus, the simultaneous presence of benzaldehyde with cis-DDP mitigates the inhibition of DNA synthesis induced by cis-DDP. However, when cells were electropermeabilized during the treatment pulse, benzaldehyde did not protect the cells from cis-DDP-induced cell inactivation. The protective effect of benzaldehyde thus seems to reside with the cell membrane and it seems that benzaldehyde, when present together with cis-DDP, partially inhibits the uptake of cis-DDP into cells. Atomic absorption spectroscopy confirmed that the simultaneous presence of 5 mM benzaldehyde halved the amount of cell-bound platinum from that measured following treatment with cis-DDP alone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3752939

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Molecular mechanisms of resistance and toxicity associated with platinating agents.

Authors:  Cara A Rabik; M Eileen Dolan
Journal:  Cancer Treat Rev       Date:  2006-11-03       Impact factor: 12.111

Review 2.  Cellular accumulation of the anticancer agent cisplatin: a review.

Authors:  D P Gately; S B Howell
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

3.  The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.

Authors:  J E Melvik; J M Dornish; E O Pettersen
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

4.  Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.

Authors:  A P Jekunen; R D Christen; D R Shalinsky; S B Howell
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

5.  Synergistic cell inactivation by cis-dichlorodiammineplatinum in combination with 1-propargyl-5-chloropyrimidin-2-one.

Authors:  J M Dornish; E O Pettersen; R Oftebro
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.